middle.news
Neurotech Secures $4M to Propel Paediatric Neurological Drug Trials
10:22am on Wednesday 17th of December, 2025 AEDT
•
Healthcare
Read Story
Neurotech Secures $4M to Propel Paediatric Neurological Drug Trials
10:22am on Wednesday 17th of December, 2025 AEDT
Key Points
Binding commitments for ~$4 million placement secured
Directors to participate with ~$250,000 subject to shareholder approval
Placement shares issued at a 23.8% discount to recent VWAP
Funds earmarked for NTI164 clinical and regulatory programs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurotech International (ASX:NTI)
OPEN ARTICLE